SEC Form D private-offering filing

Mantis Biotechnology Corp

Name: Mantis Biotechnology Corp - new SEC Form D private-offering filing, San Francisco, CA
Published: 2025-12-03

A new SEC Form D private-offering notice from San Francisco, CA, a $5,500,000 filer-stated offering target in Biotech. The source filing is one click away.

Mantis Biotechnology Corp site↗ Verified via SEC Form D

Builds AI driven digital twin models of human physiology and behavior for predictive healthcare applications; YC W26 company led by CEO Georgia Witchel.

Filed 2025-12-03Filed to raise $5,500,000First money in 2025-11-17Raised so far $4,824,999HQ (as filed) San Francisco, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified mantisbiotech.com↗Named in the filing 2 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.